Use of antianxiety agents in anxious outpatients
- 1 January 1978
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 58 (1) , 1-17
- https://doi.org/10.1007/bf00426784
Abstract
The present paper reviews the role of antianxiety agents in the treatment of nonpsychotic anxious patients. Major emphasis is placed on findings from clinical trials conducted by this research group. Consideration is given to the relative efficacy of available antianxiety agents, to patient response in relation to patterns of symptomatology, and to the degree of symptom relief experienced by drug-treated anxious patients. Also discussed are some of the many nonspecific factors that affect improvement with drug treatment in general and with the benzodiazepines in particular. It is concluded that many anxious patients are not currently receiving adequate drug treatment, and may require longer periods of drug therapy or supplemental nondrug intervention.This publication has 64 references indexed in Scilit:
- Psychopharmacologic agents: Prescription patterns of non-psychiatristsPsychosomatics, 1977
- Clinical comparison of anxiolytic drug therapyPsychological Medicine, 1974
- Thiothixene and Thioridazine in AnxietyThe British Journal of Psychiatry, 1974
- Controlled Trial of Dipotassium Clorazepate (‘Tranxene’) in AnxietyThe British Journal of Psychiatry, 1973
- OXPRENOLOL IN ANXIETYThe Lancet, 1973
- Propranolol in Neurotic and Thyrotoxic AnxietyThe British Journal of Psychiatry, 1973
- LENGTH OF TREATMENT WITH ANXIOLYTIC SEDATIVES AND RESPONSE TO THEIR SUDDEN WITHDRAWALActa Psychiatrica Scandinavica, 1973
- Object Loss Prior to Medical Admissions in JapanPsychosomatics, 1969
- A LARGE OVERDOSE OF CHLORDIAZEPOXIDEThe Lancet, 1961
- THE ASSESSMENT OF ANXIETY STATES BY RATINGPsychology and Psychotherapy: Theory, Research and Practice, 1959